Infertility, Female, Infertility Low Over Reserve, IVF
Conditions
Brief summary
The relationship between BPA elevation in urine, blood, and follicle fluid and embryo quality, IVF/ICSI outcomes.
Interventions
BPA (bisphenol A) in urine, blood and follicle fluid samples
Sponsors
Study design
Eligibility
Inclusion criteria
* patients who underwent IVF due to low ovarian reserve * patients provided urine, blood, and follicle fluid (FF) samples on the oocyte retrieval day * patients who did not smoke or use alcohol * patients did not work in the plastic industry
Exclusion criteria
* patients who underwent IVF due to unexplained infertility or tubal factor or male factor indications * patients diagnosed with endometriosis * patients with freeze-all cycles * patients having previous ovarian surgery * women with metabolic disease (such as hypertension or diabetes mellitus) * patients with a known genetic problem (male or female)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Exposure to BPA | 6 month | Concentrations of Bisphenol A (BPA) will be quantified in the urine, blood plasma, and follicular fluid (individual and pooled samples) by use of ELİSA test in women with low ovarian reserve |
Countries
Turkey (Türkiye)